Dr. Kwik's Body Intelligent Center

View Original

Heavy Metals and Bone Health

Paul Kwik

Heavy metals like cadmium, lead, and mercury, as well as chemicals such as pesticides, phthalates, and bisphenols, can disrupt bone metabolism and increase the risk of bone loss and osteoporosis. Here’s a simplified explanation of how this happens:

How Heavy Metals Affect Bone:

  1. Disrupt Calcium Balance: Metals like cadmium interfere with calcium metabolism, leading to weaker bones. Calcium is essential for bone strength, and when its balance is disturbed, bones become more brittle.

  2. Kidney Damage: Cadmium accumulates in the kidneys over time. When the kidneys are damaged, the body loses calcium through urine, which further weakens the bones.

  3. Bone Breakdown: These metals also disrupt the normal process of bone formation and breakdown. They promote bone loss by increasing the activity of cells that break down bone (osteoclasts) while reducing the activity of cells that build bone (osteoblasts).

  4. Accumulation in Bones: Metals like cadmium have a long biological half-life (10-30 years) and accumulate in bones over time, leading to chronic damage. This accumulation increases the risk of conditions like osteoporosis.

Dose-Dependent Risk:

  • The more of these metals present in the body, the higher the risk of bone problems, including fractures and osteoporosis. Even low levels of these metals can lead to health issues over time.

Historical Example:

The effects of cadmium on bone health were first seen in 1968 in Japan, where water contamination from mining led to high cadmium exposure. This caused a condition known as itai-itai disease, where people suffered from severe bone pain, kidney damage, and osteoporosis.

In short, heavy metals and certain environmental chemicals disrupt the balance of bone metabolism, leading to weaker bones and a higher risk of fractures, especially with long-term exposure.

1. Cadmium and Bone Health

  • Cadmium disrupts normal bone metabolism, making bones weaker. It damages cells that build bone (osteoblasts) and increases the activity of cells that break down bone (osteoclasts).

  • Cadmium also affects the kidneys, which are crucial for maintaining calcium balance. When kidneys are damaged by cadmium, they lose calcium through urine, weakening bones even further.

  • The kidneys also activate Vitamin D, which helps bones absorb calcium. Cadmium poisons the kidney enzyme responsible for this, reducing calcium absorption and weakening bones.

2. Study Findings

  • A large 2011 study in Sweden showed that women with higher levels of cadmium in their urine had significantly higher risks of osteoporosis. Non-smokers with high cadmium levels were even more at risk, suggesting that diet (rather than smoking) is a major source of cadmium exposure.

  • Non-smokers with high cadmium levels had a 347% increased risk of osteoporosis at the hip (femoral neck) and a 326% increased risk at the spine.

3. Sources of Cadmium

  • Cadmium is found in the environment, especially in soil and food. Crops grown with certain fertilizers and seafood from polluted waters can contain high levels of cadmium.

  • Smoking (and second-hand smoke) is another major source, as cadmium from cigarettes is more easily absorbed into the body through the lungs.

4. Strategies to Reduce Cadmium Exposure

  • Avoiding cadmium exposure: This includes stopping smoking, avoiding foods grown with certain fertilizers, and steering clear of contaminated seafood and children’s jewelry containing cadmium.

  • Increasing intake of minerals: Eating foods rich in zinc, copper, iron, and selenium can help reduce the effects of cadmium because these minerals compete with cadmium in the body.

  • Safe excretion methods: Sauna use has been found to be a safe way to slowly help the body excrete cadmium over time.

  • Supplements to consider: Copper, iron, zinc, and selenium.

In summary, cadmium exposure, whether through diet or smoking, increases the risk of osteoporosis by disrupting calcium balance, damaging bones, and impaired kidney function. Reducing exposure and supporting the body's mineral balance can help mitigate its effects.

1. Lead in Bones and Osteoporosis

  • 90% of the body’s lead is stored in the bones, where it can weaken them and lead to osteoporosis.

  • Lead was phased out in the US starting in the 1970s, but people over the age of 50 often have lead in their bones from earlier exposure. When bone is lost during menopause or aging, lead is released into the bloodstream, which can cause health issues.

2. How Lead Weakens Bones

  • Reduces Bone Formation: Lead decreases the activity of cells that build bone (osteoblasts).

  • Increases Bone Breakdown: Lead promotes the activity of cells that break down bone (osteoclasts), speeding up bone loss.

  • Disrupts Calcium Absorption: Lead impairs kidney function, reducing the body’s ability to convert vitamin D into its active form, which is needed for absorbing calcium. Less calcium means weaker bones.

3. Effects of Lead Release from Bones

  • Lead stored in bones is released during bone loss, especially during menopause. This increases blood lead levels, which has been linked to other diseases like kidney damage, high blood pressure, and even an increased risk of heart disease and death.

4. Lead’s Long Half-Life

  • Lead stays in bones for a long time—25-30 years. It can be slowly released, especially during times of bone loss, and cause health problems as it re-enters the bloodstream.

5. Strategies to Reduce Lead Exposure

  • Avoid lead exposure: This includes avoiding old lead-based paint, contaminated water in older homes, and certain foods or products from countries with poor metal regulation.

  • Slow lead removal: Natural excretion of lead is difficult. Some treatments involve oral chelation therapy, which helps bind and remove metals from the body over time, but it’s a slow process that can take months.

  • NAC, Fiber, DMSA

In summary, lead accumulates in bones, where it disrupts bone formation and contributes to osteoporosis, especially during periods of bone loss. Managing exposure and slow removal of lead from the body are key strategies for reducing its harmful effects.

Bibliography

Cadmium:
8. Gallagher CM, Kovach JS, Meliker JR. Urinary cadmium and osteoporosis in U.S. Women >or= 50 years of age: NHANES 1988-1994 and 1999-2004. Environ Health Perspect. 2008October;116(10):1338-1343. doi.org/10.1289/ehp.11452 PMID: 18941575 [PMC free article] [PubMed] [Google Scholar]
10. Roberts TL. Cadmium and Phosphorous Fertilizers: The Issues and the Science. Procedia Engineering 83 (2014) 52 – 59. doi.org/10.1016/j.proeng.2014.09.012 [Google Scholar]
11. Cadmium In Jewelry: Federal Regulators Failed To Protect Children From Cancer-Causing Metals. http://www.huffingtonpost.com/2012/10/14/cadmium-in-jewelry_n_1965192.html, accessed 4-12-14.
12. Genuis SJ, Birkholz D, Rodushkin I, Beesoon S. Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements. Arch Environ Contam Toxicol. 2011;61(2):344-357. doi.org/10.1007/s00244-010-9611-5 PMID:21057782 [PubMed] [Google Scholar]

Lead:
16. Lanphear BP, Rauch S, Auinger P, Allen RW, Hornung RW. Low-level lead exposure and mortality in US adults: a population-based cohort study. Lancet Public Health. 2018;3(4):e177-e184. PMID:29544878 [PubMed] [Google Scholar]
17. Wong AK, Beattie KA, Bhargava A, et al.Canadian Multicentre Osteoporosis Study (CaMos) Research Group . Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women. Bone. 2015October;79:58-64. PMID: 25986335 [PMC free article] [PubMed] [Google Scholar]
18. Beier EE, Maher JR, Sheu TJ, et al.. Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling. Environ Health Perspect. 2013January;121(1):97-104PMID: 23086611 [PMC free article] [PubMed] [Google Scholar]
19. Rosin A. The long-term consequences of exposure to lead. Isr Med Assoc J. 2009November;11(11):689-694. PMID: 20108558 [PubMed] [Google Scholar]
20. van Lierop AH, Appelman-Dijkstra NM, Papapoulos SE. Sclerostin deficiency in humans. Bone. 2017March;96:51-62. PMID: 27742500 [PubMed] [Google Scholar]
22. Pizzorno J, Frassetto LA, Katzinger J. Diet-induced acidosis: is it real and clinically relevant? Br J Nutr. 2010April;103(8):1185-1194. PMID: 20003625 [PubMed] [Google Scholar]
23. Cure E, Yuce S, Cure MC. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia. Minerva Endocrinol. 2013June;38(2):217-218. PMID: 23732377 [PubMed] [Google Scholar]